Jaguar Health, Inc. (NASDAQ:JAGX)

COMMUNIQUÉ DE PRESSE

publié le 10/12/2025 à 15:00, il y a 3 mois 23 jours

FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Health, Inc. (NASDAQ:JAGX) receives FDA renewal for Canalevia-CA1, a prescription drug for chemotherapy-induced diarrhea (CID) in dogs, with conditional approval extended until December 2026

Veterinary Medicine Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea FDA Renewal
BRÈVE

publiée le 08/12/2025 à 22:20, il y a 3 mois 25 jours

Jaguar Health Announces Approval of Proposals at Stockholder Meeting

Crofelemer Microvillus Inclusion Disease FDA Approval Jaguar Health Stockholder Meeting
BRÈVE

publiée le 08/12/2025 à 22:20, il y a 3 mois 25 jours

Jaguar Health annonce l'approbation de propositions lors de l'assemblée générale des actionnaires

Crofelemer Jaguar Health Approbation De La FDA Assemblée Générale Des Actionnaires Maladie À Inclusions Microvillositaires
COMMUNIQUÉ DE PRESSE

publié le 08/12/2025 à 22:15, il y a 3 mois 25 jours

Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders
Jaguar CEO Lisa Conte to present updates on near-term catalysts at Emerging Growth Conference; Initial results show crofelemer may extend infants' lives with MVID; Jaguar completes FDA meeting on crofelemer trial for MVID treatment

Crofelemer Jaguar Health Lisa Conte Emerging Growth Conference MVID
BRÈVE

publiée le 02/12/2025 à 15:05, il y a 4 mois

Jaguar Health Seeks EMA Approval for Canalevia to Treat Dog Diarrhea

Jaguar Health European Medicines Agency Dog Diarrhea Canalevia Approval Non-antibiotic Treatment
BRÈVE

publiée le 02/12/2025 à 15:05, il y a 4 mois

Jaguar Health sollicite l'approbation de l'EMA pour Canalevia dans le traitement de la diarrhée canine

Jaguar Health Agence Européenne Des Médicaments Diarrhée Du Chien Approbation De Canalevia Traitement Non Antibiotique
COMMUNIQUÉ DE PRESSE

publié le 02/12/2025 à 15:00, il y a 4 mois

Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study
Jaguar Health, Inc. requests advice from EMA on EU approval pathway for Canalevia® in treating general diarrhea in dogs. Novel non-antibiotic approach targets a significant market gap

Jaguar Health Dogs EMA Canalevia General Diarrhea
BRÈVE

publiée le 24/11/2025 à 15:05, il y a 4 mois 8 jours

Jaguar Health Strengthens IP with New Patent for Crofelemer in Intestinal Disorders

Crofelemer Patent Clinical Trials Jaguar Health Intestinal Disorders
BRÈVE

publiée le 24/11/2025 à 15:05, il y a 4 mois 8 jours

Jaguar Health renforce sa propriété intellectuelle grâce à un nouveau brevet pour le crofélémère dans le traitement des troubles intestinaux.

Crofelemer Jaguar Health Essais Cliniques Brevet Troubles Intestinaux
COMMUNIQUÉ DE PRESSE

publié le 24/11/2025 à 15:00, il y a 4 mois 8 jours

Jaguar Health Secures New Patent for Crofelemer in Short Bowel Syndrome, Strengthening Global IP Position Ahead of Additional Clinical Milestones
Jaguar Health, Inc. secures new patent expanding international IP for crofelemer in pediatric intestinal failure disorders, highlighting reductions in parenteral support. Supporting business development plans

Crofelemer Business Development Jaguar Health Inc. Pediatric Intestinal Failure New Patent

Publié le 02/04/2026 à 18:39, il y a 8 heures 49 minutes

Mersen: Disclosure of trading own shares
Publié le 02/04/2026 à 18:39, il y a 8 heures 49 minutes

Mersen : Déclaration des transactions sur actions propres
Publié le 02/04/2026 à 18:30, il y a 8 heures 59 minutes

Thales met à disposition son Document d’Enregistrement Universel 2025
Publié le 02/04/2026 à 18:30, il y a 8 heures 59 minutes

Thales makes available its Universal Registration Document 2025
Publié le 02/04/2026 à 18:22, il y a 9 heures 6 minutes

TF1 - Déclaration mensuelle des actions et droits de vote - Mars 2026

Voir tout LES ECHOS COMFI WIRE

Publié le 02/04/2026 à 22:00, il y a 5 heures 29 minutes

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Publié le 02/04/2026 à 18:32, il y a 8 heures 57 minutes

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Publié le 02/04/2026 à 15:00, il y a 12 heures 29 minutes

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Publié le 02/04/2026 à 14:40, il y a 12 heures 49 minutes

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Publié le 02/04/2026 à 14:30, il y a 12 heures 59 minutes

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

Voir tout ACCESSWIRE

Publié le 02/04/2026 à 23:55, il y a 3 heures 33 minutes

Brazil's second-crop corn can provide a low-carbon pathway for Sustainable Aviation Fuel (SAF)
Publié le 02/04/2026 à 23:05, il y a 4 heures 23 minutes

DeFi Technologies Announces Audited Full Year 2025 Financial Results with Record Revenue of $99.1 Million and Record Net Income of $62.7 Million
Publié le 02/04/2026 à 21:43, il y a 5 heures 45 minutes

EQS-Adhoc: EPH Group AG: Agreement on the Acquisition of a Resort Project in Vorarlberg
Publié le 02/04/2026 à 20:30, il y a 6 heures 58 minutes

Aquis Stock Exchange - Disciplinary Notice
Publié le 02/04/2026 à 19:52, il y a 7 heures 36 minutes

E-PANGO: Composition du capital au 31 mars 2026

Voir tout EQS

News